Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
|
|
|
|
Reflecting on the Inaugural Artificial Intelligence in Oncology Symposium
|
On October 24, the Case Comprehensive Cancer Center and the Center for Computational Imaging and Personalized Diagnostics hosted the inaugural Artificial Intelligence in Oncology Symposium on the campus of Case Western Reserve University. With the help of the planning committee, the event brought together experts in Artificial Intelligence (AI) and machine learning as well as clinical, industry and federal agency experts in pathology, radiology, oncology and immuno-oncology. In its first year, the symposium drew 270 registrants with 50 attendees tuning in to a livestream, representing 12 U.S. states and 8 countries. The response to this unique symposium was so successful that a 2020 event is already being planned.
|
|
|
|
Bolwell Recipient of 2019 Alfred and Norma Lerner Humanitarian Award
|
The Case Comprehensive Cancer Center extends congratulations to
Brian Bolwell, MD as he recently received the Cleveland Clinic's prestigious Alfred and Norma Lerner Humanitarian Award. Dr. Bolwell is Chairman of the Taussig Cancer Institute and Deputy Director for Cleveland Clinic at the Case CCC. We frequently feature his
Oncology Times leadership blog, "Straight Talk: Today's Cancer Centers" here in our newsletter;
click here to read his latest piece, "Values."
|
|
|
|
Avril Receives $100K Grant from Mary Kay Foundation
|
The Case Comprehensive Cancer Center extends congratulations to
Stefanie Avril, MD as she was recently awarded $100,000 from the Mary Kay Foundation as part of their 2019 cancer research grants. Dr. Avril is conducting groundbreaking research to harness the body's immune system to eradicate breast cancer. A University Hospitals physician, she was recently named the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research.
|
|
|
|
Brady-Kalnay Receives 2019 Women of Achievement Award
|
The Flora Stone Mather Center for Women recently celebrated their 2019 Women of Achievement. One of seven awarded at the university was Case CCC member Susann Brady-Kalnay, PhD. Dr. Brady-Kalnay is professor of molecular biology and microbiology, neurosciences and pathology in the School of Medicine at CWRU. Congratulations!
|
|
|
|
Cancer-focused Summer Undergraduate Research (CanSUR) Program Applications Now Open
|
The Cancer-focused Summer Undergraduate Research (CanSUR) Program aims to generate excitement for a future career in cancer research in highly motivated undergraduates and help them prepare for the next stage of their careers. The program supports 32 undergraduates from colleges and universities from across the country to work with Case Comprehensive Cancer Center (Case CCC) researchers over a 10-week period each summer. Applications for the 2020 program are now open and will be accepted through January 15, 2020. Priority acceptance of exceptional applicants will be made on a rolling basis.
|
|
|
|
Hear from Sanford Simon, PhD and Theresa Beech, PhD Next Week at the Innovators in AYA Cancer Symposium
|
Next week's
Innovators in AYA Cancer Symposium will feature two Keynote presentations. Thursday afternoon we will hear from
Sanford Simon, PhD, head of Laboratory of Cellular Biophysics at The Rockefeller University. His talk is titled, "A Patient-Clinician-Research Partnership for the Development of Diagnostics and Therapeutics for a Childhood Cancer, Fibrolamellar Hepatocellular Carcinoma."
We hope you are able to join us for this symposium where leaders will highlight strategies designed to enhance our understanding of the biology of AYA cancers, selected treatment modalities and clinical trial objectives for cancers common to AYA patients including specific advances in immunotherapy, targeted tumor-based therapy, and efforts focused on survivorship.
|
|
Mon, Nov 11
Shared Resources Directors Meeting
12p WRB 1-422D
|
|
Tues, Nov 12
Immuno-Oncology Seminar Series
Weiping Zou, MD, PhD
1p NE1-205
CAR-T Cell Working Group
3p WRB 2-136
|
|
Weds, Nov 13
HemOnc Grand Rounds Recruitment Seminar
Bahar Laderian, MD
8a Wearn 137
Disparities SPORE Monthly Meeting
Topic: Consensus on Neighborhood Disadvantage Index
A light dinner will be served.
5-7p WRB 2-136
|
|
Thurs, Nov 14
Angie Fowler Grand Rounds
Theresa Beech, PhD
8a Rainbow Amphitheater Rm 123
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immunology Journal Club
12p WRB 5-136
Molecular Biology and Microbiology Seminar
Carlin Lab
1p SOM W203
|
|
Fri, Nov 15
Taussig Cancer Institute Grand Rounds
8a CA5-120
UH HemOnc Grand Rounds
Afshin Dowlati, MD
8a Wearn 137
|
|
|
Mon, Nov 18
Cancer Center Research Chalk Talk
Mark Jackson, PhD
1p WRB 3-136
WRB Faculty Meetings with Stan Gerson
3:30p WRB 3-136
Open to the entire CWRU community!
4-5p Tinkham Veale Ballroom A
|
|
Tues, Nov 19
Cancer Drug Discovery and Resistance
3p WRB 1-422D
|
|
Weds, Nov 20
Biomedical Innovation and Entrepreneur Club
4-6p BRB 932
|
|
Thurs, Nov 21
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immunology Journal Club
12p WRB 5-136
Molecular Biology and Microbiology Seminar
Uri Mbonye and Kien Nguyen
1p SOM W203
Clinical Research Retreat
5-7p NE1-205
|
|
Fri, Nov 22
Taussig Cancer Institute
Grand Rounds
Jaleh Fallah, MD
8a CA5-120
Cancer Center Seminar Series
Michael Rape, PhD
12p WRB Auditorium
|
|
|
 |
Cancer Center Seminar Series
November 8, 12p
WRB Auditorium
Today at noon, our seminar will return to the WRB Auditorium and feature Johnie Rose, MD, PhD presenting, Using Data to Target Cancer Control and Prevention."
Dr. Rose is Assistant Professor, Center for Community Health Integration, Co-Director of the Population Cancer Analytics Shared Resource, and member of the Cancer Prevention, Control & Population Research Program at the Case Comprehensive Cancer Center.
His research applies a range of data science methods to guide intervention and data collection with the overarching goal of improving population cancer prevention and control.
For this seminar, Dr. Rose will describe recent work building a cancer informatics data infrastructure which captures multi-level data on catchment area cancer outcomes and population. He will also cover his computer modeling work which simulates recurrence of colon cancer among successfully treated patients with Stage I to III disease. The model has been ‘trained’ using clinical trial data and externally validated. It can be used to predict the outcomes of user-defined groups of survivors under alternative surveillance regimens and to determine optimal regimens for a given group.
|
|
|
|
Innovators in AYA Cancer Symposium
November 14-15, 2019
Tinkham Veale University Center
The Angie Fowler Adolescent and Young Adult (AYA) Cancer Research Initiative of the Case Comprehensive Cancer Center invites you to attend Innovators in AYA Cancer: Driving Science and Policy toward a Brighter Future for Teens and Young Adults with Cancer this November at Case Western Reserve University. The symposium will feature expert talks researchers, patients and survivors on sarcoma, immunotherapy, clinical trials, policy and survivorship.
Register today to save your seat! A discount for students and trainees who wish to attend is available. We look forward to seeing you in November!
|
|
|
|
|
2019 Clinical Research Retreat
November 21, 5-7p
Taussig Cancer Center CA5-120
The Case Comprehensive Cancer Center will host the Clinical Research Retreat, a semi-annual showcase of clinical cancer research across our institutions from 5-7 pm on Thursday, November 21 at Cleveland Clinic Taussig Cancer Institute, CA5-120.
The evening's
agenda is focused on two timely and exciting areas of cancer clinical research. First, attendees will hear from current NCI K12 Paul Calabresi Scholars, Molly Gallogly, Roberto Vargas, Kristen VanHeyst and Haider Mahdi who will discuss their innovative investigator initiated treatment (IIT) protocol that is based on preclinical models. Since development of an exciting IIT protocol takes a village, your feedback will be important.
Secondly,
Charles Kunos, MD, PhD, a clinical investigator and protocol reviewer at CTEP, NCI will deliver his keynote address, "Engaging CTEP in early phase radiopharmaceutical trials" updating us on innovative approaches to evaluate this drug class. Dr. Kunos is a graduate of our long-standing K12 program and was a member of the
Case CCC before moving on to the NCI.
|
|
|
|
4th Annual Cancer Disparities Symposium
March 6, 2020
Tinkham Veale University Center
The Case Comprehensive Cancer Center Office of Cancer Disparities Research will present the
4th Annual Cancer Disparities Symposium
: Cultivating Science and Community Engagement to Address Cancer Health Disparities on March 6, 2020.
The symposium will feature keynote presentations by renowned disparities researchers and community leaders, a poster session highlighting academic research and community programs, networking opportunities and an interactive panel discussion.
Call for Abstracts
The
4th Annual Cancer Disparities Symposium is a premier event for presenting cutting-edge cancer disparities science and related community programs and services. The Office of Cancer Disparities Research will divide abstracts into two tracks:
Scientific Research
and
Community Programs and Services. Scientific Research abstracts are encouraged from multidisciplinary researchers that are focused on various aspects of health disparities and/or community-focused science. Community programs and service abstracts are encouraged from organizations that provide programs and services that benefit the community. Meritorious abstracts will be selected for oral presentation.
Abstracts must be submitted electronically by 5p EST on Tuesday, December 3, 2019. Students who submit an abstract prior to registration are able to register for free!
Learn more>
Travel Scholarships
New for 2020, a limited number of Travel Scholarships are available to provide travel support to the symposium.
Application details>
|
|
|
|
Additional Upcoming Events
|
|
|
Cleveland Clinic Best of Radiation Oncology 2019
November 9, 2019
Independence, OH
|
|
|
|
Cleveland Clinic Breast Cancer Update: From Detection Through Treatment to Survivorship
November 13, 2019
Independence, OH
|
|
|
|
|
Biomedical Innovation and Entrepreneurship Club
November 20, 4-6p
BRB 932
|
Join the CWRU Biomedical Innovation and Entrepreneurship Club for a discussion and networking happy hour to learn about what is involved in getting a product ready for clinical trials! This month's guest is Laura Dixon, PhD (SOM '13) Clinical Research Regulatory Specialist at University Hospitals.
|
|
|
|
Cleveland Clinic Children's Pediatric Lecture Series
November 25, 8a
Cleveland Clinic R3-002/003
|
Join Cleveland Clinic Children's for "The Science of Pediatric Blood & Cancer" Lecture Series featuring
Gregory H. Reaman, MD presenting, "Pediatric Cancer Drug Development: The Road Well Traveled by the Therapeutic Orphans - Construction Ahead."
|
|
|
|
|
High Risk Germline Focus Group
December 9, 5:15-6:45p
Cleveland Clinic NE5-218
|
|
|
|
NCCN 2020 Annual Conference
March 20-22, 2020
Orlando, FL
|
|
|
|
Deadlines Vary
Deadlines for funding opportunities through the Case Comprehensive Cancer Center are fast approaching! Please note the upcoming deadlines below and view a complete list of opportunities
on our website.
Deadline: Friday, Nov 8, 2019
Deadline: Friday, Nov 8, 2019
Deadline: Friday, Nov 8, 2019
LOI Deadline: Monday, Nov 18, 2019
|
|
Fox 8 Cleveland - Oct 21, 2019
"This is a combination of multiple techniques, including breathing techniques, where the patient breathes in, which lifts the breast and chest away from the heart, with radiation delivered when that separation occurs," explains Cleveland Clinic's
Chirag Shah, MD, member of the Case CCC's Molecular Oncology Program.
|
|
Journal of Clinical Pathways - Oct 31, 2019
“These guidelines provide an algorithmic pathway for a systematic approach to allogeneic (donor) transplantation across several different cancer types, including leukemia, lymphoma, and multiple myeloma,” said
Marcos de Lima, MD, professor of medicine, Case Comprehensive Cancer Center and University Hospitals of Cleveland, and vice chair of the NCCN guideline panel for HCT.
|
|
|
|
Dr. Ned Sharpless Resumes Leadership of the National Cancer Institute
|
Earlier this year, Dr. Sharpless was asked by the President to step in as Acting Commissioner of the US Food and Drug Administration while they sought a permanent candidate. Stephen Hahn, MD, Chief Medical Executive of The University of Texas MD Anderson Cancer Center has been nominated by the President for the role of Commissioner and is awaiting Senate confirmation.
|
|
Weekly NIH Funding Opportunities and Notices
|
Notices
Funding Opportunities
Standard Dates Apply
|
|
Use the button below to submit all your news, events, announcements and communications requests to the Case CCC Marketing and Communications team!
|
|
|
|
|
|
|
